Seroatlas · Human Serome Atlas

CRHBP

Corticotropin-releasing factor-binding protein

Also known as: CRF-BP, CRFBP, CRHBP_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P24387
Gene
CRHBP
Ensembl
ENSG00000145708
Chromosome
5
Canonical length
322 aa
Protein class
Plasma proteins, Predicted secreted proteins
Secretome location
Secreted to blood

OverviewNCBI Gene

Corticotropin-releasing hormone is a potent stimulator of synthesis and secretion of preopiomelanocortin-derived peptides. Although CRH concentrations in the human peripheral circulation are normally low, they increase throughout pregnancy and fall rapidly after parturition. Maternal plasma CRH probably originates from the placenta. Human plasma contains a CRH-binding protein which inactivates CRH and which may prevent inappropriate pituitary-adrenal stimulation in pregnancy. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

322 residues, UniProt reviewed canonical sequence.

>P24387|CRHBP
     1  MSPNFKLQCH FILIFLTALR GESRYLELRE AADYDPFLLF SANLKRELAG EQPYRRALRC
    61  LDMLSLQGQF TFTADRPQLH CAAFFISEPE EFITIHYDQV SIDCQGGDFL KVFDGWILKG
   121  EKFPSSQDHP LPSAERYIDF CESGLSRRSI RSSQNVAMIF FRVHEPGNGF TLTIKTDPNL
   181  FPCNVISQTP NGKFTLVVPH QHRNCSFSII YPVVIKISDL TLGHVNGLQL KKSSAGCEGI
   241  GDFVELLGGT GLDPSKMTPL ADLCYPFHGP AQMKVGCDNT VVRMVSSGKH VNRVTFEYRQ
   301  LEPYELENPN GNSIGEFCLS GL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CRHBP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.33
Highest tissue expression
156 nTPM

Expression across tissuesHPA

Tissue

  • liver: 156 nTPM
  • hypothalamus: 57 nTPM
  • kidney: 42 nTPM
  • spleen: 35 nTPM
  • adipose tissue: 21 nTPM
  • adrenal gland: 15 nTPM

Single-cell type

  • hematopoietic stem cells: 2,019 nCPM
  • megakaryocyte-erythroid progenitors: 214 nCPM
  • vascular endothelial cells: 123 nCPM
  • kupffer cells: 65 nCPM
  • thymocytes: 63 nCPM
  • megakaryocyte progenitors: 20 nCPM

Immune cell

  • neutrophil: 0.1 nTPM
  • total PBMC: 0.1 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM

Brain region

  • thalamus: 38 nTPM
  • hypothalamus: 30 nTPM
  • pons: 22 nTPM
  • midbrain: 16 nTPM
  • cerebral cortex: 13 nTPM
  • medulla oblongata: 12 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.58
gnomAD pLI
0.21
gnomAD missense Z
1.35
DepMap mean gene effect
-0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

  • Spermadhesin, CUB domain superfamily
  • Corticotropin-releasing factor-binding protein
  • Corticotropin-releasing factor binding protein, N-terminal domain
  • Corticotropin-releasing factor binding protein, C-terminal domain
  • Corticotropin-releasing factor binding protein N-terminal domain
  • Corticotropin-releasing factor binding protein C-terminal domain

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CRHBP as an antibody target. Whether an autoantibody or antibody against CRHBP could matter depends on whether native CRHBP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CRHBP is annotated as secreted, so native CRHBP circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label CRHBP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/CRHBP. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...